Highly drug/target-tolerant neutralizing antibody (NAb) assay development through target-based drug depletion and drug-based NAb extraction for an anti-EGFR therapeutic monoclonal antibodyRongrong Fu, Qingcheng Guo, Weizhu Qian et al.|Journal of Pharmaceutical and Biomedical Analysis|2024Cited by 0